Abstract
Methamphetamine is known to cause a cardiomyopathy which may be reversible with appropriate medical therapy and cessation of use. Late gadolinium enhancement cardiovascular magnetic resonance (CMR) has been shown to identify fibrosis in ischemic and non-ischemic cardiomyopathies. We present a case of severe methamphetamine-associated cardiomyopathy in which cardiac function recovered after 6 months. Evaluation by CMR using late gadolinium enhancement was notable for an absence of enhancement, suggesting an absence of irreversible myocyte injury and a good prognosis. CMR may be useful to predict recovery in toxin-associated non-ischemic cardiomyopathies.
| Original language | English (US) |
|---|---|
| Article number | 46 |
| Journal | Journal of Cardiovascular Magnetic Resonance |
| Volume | 11 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2009 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
- Radiological and Ultrasound Technology
- Family Practice
- Medicine(all)
Fingerprint Dive into the research topics of 'Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance'. Together they form a unique fingerprint.
Cite this
Lopez, J. E., Yeo, K., Caputo, G., Buonocore, M. H., & Schaefer, S. (2009). Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 11(1), [46]. https://doi.org/10.1186/1532-429X-11-46